Skip to main content
SpringerLink
Log in

Cardiac Arrhythmias

  • Chapter
Family Medicine

  • 32 Accesses

Abstract

Cardiac arrhythmias are frequently seen in routine primary care practice, and “palpitations” or patient concerns about “skipped heartbeats” are among the most common presenting complaints in primary care. Surprisingly, many symptomatic patients do not have significant cardiac arrhythmias, whereas a substantial proportion of clinically significant arrhythmias are detected in asymptomatic patients. As more information has become available regarding the natural history of many arrhythmias in the primary care setting, we are moving from an era of overtreatment via aggressive pharmacologic management to an era of selective treatment with increased use of nonpharmacologic interventions such as surgical or catheter ablation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Graboys T. Appropriate indications for ambulatory electrocardiographic monitoring. Cardiol Clin 1992;10:551–4.

    PubMed  CAS  Google Scholar 

  2. Weitz HH, Weinstock PJ. Approach to the patient with palpitations. Med Clin North Am 1995;79:449–57.

    PubMed  CAS  Google Scholar 

  3. Manning WJ, Silverman DI, Gordon SPF, Krumholz HM, Douglas PJ. Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude presence of atrial thrombi. N Engl J Med 1993;328:750–6.

    Article  PubMed  CAS  Google Scholar 

  4. Ukani ZA, Ezekowitz MD. Contemporary management of atrial fibrillation. Med Clin North Am 1995;79:1135–52.

    PubMed  CAS  Google Scholar 

  5. Waldo AL. An approach to therapy of supraventricular tachyarrhythmias: an algorithm versus individualized therapy. Clin Cardiol 1994;17 Suppl II:21–6.

    Google Scholar 

  6. Wilber DJ, Olshamsky B, Moral JF, et al. Electrophysiological testing and nonsustained ventricular tachycardia: use and limitations in patients with coronary artery disease and impaired ventricular function. Circulation 1990;82:350–8.

    Article  PubMed  CAS  Google Scholar 

  7. Hamdan M, Scheinman M. Current approaches in patients with ventricular tachyarrhythmias. Med Clin North Am 1995; 79:1097–1120.

    PubMed  CAS  Google Scholar 

  8. Gomes JA, Mehta D, Langan MN. Sinus node reentrant tachycardia. PACE 1995;18(Part I):1045–57.

    Article  PubMed  CAS  Google Scholar 

  9. Huang SK. Radio-frequency catheter ablation of cardiac arrhythmias: appraisal of an evolving therapeutic modality. Am Heart J 1989;118:1317–29.

    Article  PubMed  CAS  Google Scholar 

  10. Chun HM, Sung RJ. Supraventricular tachyarrhythmias. Med Clin North Am 1995;79:1121–34.

    PubMed  CAS  Google Scholar 

  11. Vaughan-Williams EM. A classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol 1984;24:129–47.

    Article  PubMed  CAS  Google Scholar 

  12. Epstein AE, Bigger JT, Wyse GD, et al. Events in the Cardiac Arrhythmia Suppression Trial (CAST): mortality in the entire population enrolled. J Am Coll Cardiol 1991;18:14–19.

    Article  PubMed  CAS  Google Scholar 

  13. Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecanide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406–12.

    Google Scholar 

  14. Cardiac Arrhythmia Suppression Trial-II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992;327:227–33.

    Google Scholar 

  15. Beta-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. JAMA 1982;247:1707–14.

    Google Scholar 

  16. Teo KK, Yusuf S, Furberg CD. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction: an overview of the results from randomized controlled trials. JAMA 1993;270:1589–95.

    Article  PubMed  CAS  Google Scholar 

  17. Burkart B, Pfisterer M, Kiowski W, et al. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS). J Am Coll Cardiol 1990;16:1711–8.

    Article  PubMed  CAS  Google Scholar 

  18. CASCADE Investigators. Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE study). Am J Cardiol 1991;67:578–84.

    Google Scholar 

  19. Mason JW, for the Electrophysologic Study versus Electrocardiographic Monitoring Investigators. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. N Engl J Med 1993;329:452–8.

    Article  PubMed  CAS  Google Scholar 

  20. Kirschenbaum HL, Rosenberg JM. Clinical experience with sotalol in the treatment of cardiac arrhythmias. Clin Ther 1994;16:347–65.

    Google Scholar 

  21. Alpert MA, Hashimi MW, Concannon MD, Bikkina M, Mukerji V. Pathogenesis, recognition, and management of common cardiac arrhythmias. Part II. Supraventricular premature beats and tachyarrhythmias. South Med J 1995; 88:153–74.

    Article  PubMed  CAS  Google Scholar 

  22. Vukmir RB. Cardiac arrhythmia therapy. Am J Emerg Med 1995;13:459–70.

    Article  PubMed  CAS  Google Scholar 

  23. Kerin NZ, Somberg J. Proarrhythmia: definition, risk factors, causes, treatment, and controversies. Am Heart J 1994;128: 575–85.

    Article  PubMed  CAS  Google Scholar 

  24. Faber TS, Zehender M, Just H. Drug-induced torsade de pointes: incidence, management and prevention. Drug Saf 1994;11:463–76.

    Article  PubMed  CAS  Google Scholar 

  25. Wellens HJJ, Atie J, Penn OC, Gorgels APM, Brugada P, Smeets J. Diagnosis and treatment of patients with accessory pathways. Cardiol Clin 1990;8:503–21.

    PubMed  CAS  Google Scholar 

  26. Cox JL, Ferguson BT. Cardiac arrhythmia surgery. Curr Probl Surg 1989;26:199–221.

    Article  Google Scholar 

  27. Cox J, Ferguson BT, Lindsay BD, et al. Perionodal cryosurgery for atrioventricular node reentry tachycardia in 23 patients. J Thorac Cardiovasc Surg 1990;90:490–6.

    Google Scholar 

  28. Kadish A, Goldberger J. Ablative therapy for atrioventricular nodal reentry arrhythmias. Prog Cardiovasc Dis 1995; 37:273–293.

    Article  PubMed  CAS  Google Scholar 

  29. Kupersmith J, Holmes-Rovner M, Hogan A, Rovner D, Gardiner J. Cost-effectiveness analysis in heart disease. III. Ischemia, congestive heart failure, and arrhythmias. Prog Cardiovasc Dis 1995;37:307–46.

    Article  PubMed  CAS  Google Scholar 

  30. Winkle RA, Mead RH, Ruder MA, et al. Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol 1989:13:1353–61.

    Article  PubMed  CAS  Google Scholar 

  31. Sung RJ, Lauer MR, Chun H. Atrioventricular node reentry: current concepts and new perspectives. Pacing Clin Electrophysiol 1994;17:1413–30.

    Article  PubMed  CAS  Google Scholar 

  32. Schwartz M, Rodman D, Lowenstein S. Recognition and treatment of multifocal atrial tachycardia: a critical review. J Emerg Med 1994;12:353–60.

    Article  PubMed  CAS  Google Scholar 

  33. DeMarco JP, Miles W, Akhtar M, et al. Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil: assessment in placebo-controlled, multicenter trials. Ann Intern Med 1990;113:104–10.

    Article  Google Scholar 

  34. Camm AJ, Garratt CJ. Adenosine and supraventricular tachycardia. N Engl J Med 1991;325:1621–7.

    Article  PubMed  CAS  Google Scholar 

  35. Waldo AL. Clinical evaluation and therapy of patients with atrial fibrillation and flutter. Cardiol Clin 1990;8:479–90.

    PubMed  CAS  Google Scholar 

  36. Wolf PA, Abbott R, Savage D. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 1991;22:983–8.

    Article  PubMed  CAS  Google Scholar 

  37. Petersen P, Boysen G, Godtfredson J, Andersen E, Andersen B. Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study. Lancet 1989;1:175–9.

    Article  PubMed  CAS  Google Scholar 

  38. Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C. Canadian Atrial Fibrillation Anticoagulation (CAFA) study. J Am Coll Cardiol 1991;18:349–55.

    Article  PubMed  CAS  Google Scholar 

  39. Ezekowitz MD, Bridges SL, James KE, et al. Warfarin in the prevention of stroke associated with nonrheumatic atrialfibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med 1992; 327:1406–12.

    Article  PubMed  CAS  Google Scholar 

  40. Stroke Prevention in Atrial Fibrillation Investigators. Stroke Prevention in Atrial Fibrillation Study: final results. Circulation 1991;84:527–39.

    Google Scholar 

  41. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990;323:1505–11.

    Google Scholar 

  42. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449–57.

    Google Scholar 

  43. Matchar DB, McCrory DC, Barnett HJM, Feussner JR. Medical treatment for stroke prevention. Ann Intern Med 1994; 121:41–53.

    Article  PubMed  CAS  Google Scholar 

  44. Gage BF, Cardinalli AB, Albers GW, Owens DK. Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation. JAMA 1995;274: 1839–45.

    Article  PubMed  CAS  Google Scholar 

  45. Arnold AZ, Mick MJ, Mazurck RP, Loup FD. Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter. J Am Coll Cardiol 1992;19:851–5.

    Article  PubMed  CAS  Google Scholar 

  46. Alpert MA, Mukerji V, Bikkina M, Concannon MD, Hashimi MW. Pathogenesis, recognition, and management of common cardiac arrhythmias. I. Ventricular premature beats and tachyarrhythmias. South Med J 1995;88:1–21.

    Article  PubMed  CAS  Google Scholar 

  47. Aronow WS. Treatment of ventricular arrhythmias in older adults. J Am Geriatr Soc 1995;43:688–95.

    PubMed  CAS  Google Scholar 

  48. Kerin NZ, Somberg J. Proarrhythmia: definition, risk factors, causes, treatment, and controversies. Am Heart J 1994;128: 575–85.

    Article  PubMed  CAS  Google Scholar 

  49. Roden DM. Risks and benefits of antiarrhythmic therapy. N Engl J Med 1994;331:785–91.

    Article  PubMed  CAS  Google Scholar 

  50. Gilman JK, Jala S, Naccarelli GV. Predicting and preventing sudden death from cardiac causes. Circulation 1994;90: 1083–92.

    Article  PubMed  CAS  Google Scholar 

  51. Hohnloser S, Woasley R. Sotalol. N Engl J Med 1994;331:31–8.

    Article  CAS  Google Scholar 

Download references

Authors
  1. Michael S. Klinkman
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Family Medicine, Oregon Health Sciences University, Portland, OR, 97201, USA

    Robert B. Taylor M.D. (Professor and Chairman) (Professor and Chairman)

  2. Department of Family Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, 45267, USA

    Alan K. David M.D. (The Fred Lazarus, Jr., Professor and Director) (The Fred Lazarus, Jr., Professor and Director)

  3. Department of Family Medicine, St. John’s Mercy Medical Center, St. Louis, MO, 63141, USA

    Thomas A. Johnson Jr. M.D. (Chairman) (Chairman)

  4. Department of Family Medicine, University of Mississippi School of Medicine, Jackson, MS, 39216, USA

    D. Melessa Phillips M.D. (Professor and Chairman) (Professor and Chairman)

  5. Department of Family Medicine, University of California—Irvine College of Medicine, Orange, CA, 92697, USA

    Joseph E. Scherger M.D., M.P.H. (Associate Dean for Primary Care and Chair) (Associate Dean for Primary Care and Chair)

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Klinkman, M.S. (1998). Cardiac Arrhythmias. In: Taylor, R.B., David, A.K., Johnson, T.A., Phillips, D.M., Scherger, J.E. (eds) Family Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-2947-4_77

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-2947-4_77

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4757-2949-8

  • Online ISBN: 978-1-4757-2947-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation